RNS Number:3911T
CeNeS Pharmaceuticals PLC
17 December 2003


                   CENES PHARMACEUTICALS PLC ("the Company")

                                HOLDING IN COMPANY



The Company has been notified that following the Company's acquisition of
TheraSci Limited announced on 24 November 2003, Avlar Bioventures Fund II
Limited Partnership has an interest in 22,786,596 ordinary shares of 1p each in
the Company, representing 9.1 per cent. of the current issued share capital of
the Company.



Further information

Neil Clark, CeNeS Pharmaceuticals plc   01223 266 466

17 December 2003




                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
HOLUBUNROBRUAAA